Industry News
Should Parents Disclose A Genetic Predisposition To Breast Cancer To Their Children?
Apr 03, 2012
When a mother undergoes genetic testing to determine whether she carries a gene for hereditary breast cancer, the parents must then decide whether and how to share this risk information with their children... Read More
Galeterone Shown To Be Safe, Effective Against Prostate Cancer In Phase I Trial
Apr 03, 2012
Patients with castration-resistant prostate cancer had limited side effects and in many cases a drop in prostate-specific antigen expression with galeterone (TOK-001), a small-molecule oral drug, according to phase I data presented at the AACR Annual Meeting 2012, being held March 31 - April 4... Read More
Prostate Cancer Recurrence Predicted By Oxygen In Tumors
Apr 03, 2012
Low oxygen levels in tumors can be used to predict cancer recurrence in men with intermediate-risk prostate cancer even before they receive radiation therapy... Read More
Detection Of Lung Cancers Via CT Screening As Successful As Traditional Methods
Apr 03, 2012
A new study led by researchers at Mount Sinai School of Medicine indicates that CT scans are more effective than traditional lung cancer detection methods at identifying aggressive lung cancers in their most treatable stages... Read More
Stem Cells From Intestinal Crypt Lead Researchers To Cancer Discovery
Apr 03, 2012
Tales from the crypt are supposed to be scary, but new research from Vanderbilt University, the HudsonAlpha Institute for Biotechnology and colleagues shows that crypts can be places of renewal too: intestinal crypts, that is. Intestinal crypts are small areas of the intestine where new cells are formed to continuously renew the digestive tract... Read More
Laying The Foundation For Personalized Cancer Treatment Using DNA Sequencing
Apr 03, 2012
Scientists at Washington University School of Medicine in St. Louis are using powerful DNA sequencing technology not only to identify mutations at the root of a patient's tumor - considered key to personalizing cancer treatment - but to map the genetic evolution of disease and monitor response to treatment... Read More
Identification Of Biomarker In Relation To Drug Response In Refractory Urothelial Cancer
Apr 03, 2012
The antiangiogenic drug pazopanib has demonstrated clinically meaningful activity in patients with refractory urothelial cancer, according to results presented at the AACR Annual Meeting 2012, held here March 31 - April 4. The results also revealed that increases in interleukin-8 levels early after treatment with pazopanib may predict a lack of tumor response to the therapy... Read More
Researchers Control Drug Side Effects For Treatment Gains In Phase I Trial Of 2 Targeted Therapies Against Ewing's Sarcoma Tumors
Apr 03, 2012
A pair of targeted therapies shrank tumors in some patients with treatment-resistant Ewing's sarcoma or desmoplastic small-round-cell tumors, according to research led by investigators from The University of Texas MD Anderson Cancer Center reported at the AACR Annual Meeting 2012... Read More
Diabetes Drug Metformin May Help To Prevent Primary Liver Cancer
Apr 03, 2012
Metformin, a drug widely used to treat Type II diabetes, may help to prevent primary liver cancer, researchers at the University of Maryland Marlene and Stewart Greenebaum Cancer Center report in the April 2012 issue of Cancer Prevention Research... Read More
Metastatic Breast Cancer And Arthritis Link
Apr 03, 2012
New research shows it may be no accident when doctors observe how patients suffering from both breast cancer and arthritis seem to have more aggressive cancer. However, the new-found interaction between the two diseases may also suggest a possible treatment... Read More
Previous Page Next Page